Literature DB >> 17316141

High thrombopoietin concentrations in the cerebrospinal fluid of neonates with sepsis and intraventricular hemorrhage may contribute to brain damage.

Anke Reinhold1, Juan Zhang, Reinhard Gessner, Ursula Felderhoff-Mueser, Michael Obladen, Christof Dame.   

Abstract

Thrombopoietin (TPO) and its receptor (TPOR) are expressed in the central nervous system (CNS). Although TPO shares significant homology with various neurotrophins, recent data indicate a proapoptotic function of TPO in the CNS. In this study, TPO concentrations were analyzed in the cerebrospinal fluid (CSF) of neonates. Human neuroblastoma-derived SH-SY5Y cells were established to elucidate the effects of inflammation and hypoxia on neuronal Tpo expression. TPO was detectable in the CSF of 6 of 15 neonates with bacterial infection/sepsis (median 140, range 2-613 pg/mL), 5 of 9 neonates with posthemorrhagic hydrocephalus (median 31, range 1.4-469 pg/mL), 3 of 4 neonates with posthemorrhagic hydrocephalus plus bacterial infection/sepsis or meningitis (median 97, range 6-397 pg/mL), but not in controls ( n = 3). Neither the presence of detectable TPO nor its level in the CSF significantly correlated with any clinical or laboratory parameter. In SH-SY5Y cells, TPO and TPOR expression was detected by RT-PCR and Western blot analysis. In vitro, interleukin-6 (IL-6) did not significantly change Tpo gene expression. In contrast, Tpo mRNA expression significantly decreased under hypoxia, whereas erythropoietin (EPO) mRNA expression increased. In conclusion, our data provide evidence that in neuronal cells, TPO production is regulated by different mechanisms than in hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316141     DOI: 10.1089/jir.2006.0096

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  9 in total

1.  Thrombopoietin contributes to neuronal damage in experimental bacterial meningitis.

Authors:  Olaf Hoffmann; Olga Rung; Ae-Rie Im; Dorette Freyer; Juan Zhang; Josephin Held; Werner Stenzel; Christof Dame
Journal:  Infect Immun       Date:  2010-12-13       Impact factor: 3.441

Review 2.  Prognostic Value of Platelet to Lymphocyte Ratio in Sepsis: A Systematic Review and Meta-analysis.

Authors:  Gancheng Wang; Azam Mivefroshan; Shirin Yaghoobpoor; Shokoufeh Khanzadeh; Goli Siri; Farzad Rahmani; Samira Aleseidi
Journal:  Biomed Res Int       Date:  2022-06-06       Impact factor: 3.246

Review 3.  New concepts in the pathogenesis of hydrocephalus.

Authors:  Satish Krishnamurthy; Jie Li
Journal:  Transl Pediatr       Date:  2014-07

Review 4.  Biomarkers in neonatal posthemorrhagic hydrocephalus.

Authors:  Stephanie Merhar
Journal:  Neonatology       Date:  2011-07-27       Impact factor: 4.035

5.  Expression pattern of the thrombopoietin receptor (Mpl) in the murine central nervous system.

Authors:  Anna Ivanova; Jens Wuerfel; Juan Zhang; Olaf Hoffmann; Matthias Ballmaier; Christof Dame
Journal:  BMC Dev Biol       Date:  2010-07-28       Impact factor: 1.978

6.  Levels of thrombopoietin in aqueous humor of patients with noninfectious acute anterior uveitis.

Authors:  José-Juan Mondejar; David Salom; Salvador Garcia-Delpech; Manuel Diaz-Llopis
Journal:  Clin Ophthalmol       Date:  2015-07-13

7.  Intraventricular infusion of hyperosmolar dextran induces hydrocephalus: a novel animal model of hydrocephalus.

Authors:  Satish Krishnamurthy; Jie Li; Lonni Schultz; James P McAllister
Journal:  Cerebrospinal Fluid Res       Date:  2009-12-11

Review 8.  Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases.

Authors:  Enrico Lupia; Alberto Goffi; Ornella Bosco; Giuseppe Montrucchio
Journal:  Mediators Inflamm       Date:  2012-04-05       Impact factor: 4.711

Review 9.  A proposed role for efflux transporters in the pathogenesis of hydrocephalus.

Authors:  Satish Krishnamurthy; Michael D Tichenor; Akhila G Satish; David B Lehmann
Journal:  Croat Med J       Date:  2014-08-28       Impact factor: 1.351

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.